Microbiome research

ZEISS have established a partnership with microbiome analytics firm Perseus Biomics. The partnership aims to develop an optical technology for microbiome research, specifically the quantitative analysis of the microbiome.
“The microbiome is a field of strong research interest with the potential to fundamentally change our understanding of living systems. Abundance analysis of the microbiome is one key element of this research and Perseus’ innovative optical technology has the potential to enable it at a new level,” said Gerrit Schulte, Head of ZEISS Ventures.
“We have assembled a first-class scientific and R&D team that aims to revolutionise microbiome analysis, making it faster, more precise and more affordable, while opening the way for broad-reach personalised medicine,” said Walid N. Hanna, Executive Chairman of Perseus.
https://www.zeiss.com/
Latest Articles
ESCRS Today 2025: Happy Anniversaries!
ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.
ESCRS Today 2025: A Congress for Everyone
From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.
Beyond the Numbers
Empowering patient participation fosters continuous innovation in cataract surgery.
Thinking Beyond the Surgery Room
Practice management workshop focuses on financial operations and AI business applications.
Aid Cuts Threaten Global Eye Care Progress
USAID closure leads retreat in development assistance.
Supplement: ESCRS Clinical Trends Series: Presbyopia
Debate: FS-LASIK or KLEx for Hyperopia?
FS-LASIK has more of a track record, but KLEx offers advantages.
Four AI Applications Ready for Practice
Commercial offerings may save time, improve practice and research.
Perioperative Medication Regimens for Cataract Surgery
Randomised controlled clinical trial results provide evidence-based guidance.